172 related articles for article (PubMed ID: 15153426)
1. Molecular signaling of somatostatin receptors.
Lahlou H; Guillermet J; Hortala M; Vernejoul F; Pyronnet S; Bousquet C; Susini C
Ann N Y Acad Sci; 2004 Apr; 1014():121-31. PubMed ID: 15153426
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptors.
Benali N; Ferjoux G; Puente E; Buscail L; Susini C
Digestion; 2000; 62 Suppl 1():27-32. PubMed ID: 10940684
[TBL] [Abstract][Full Text] [Related]
3. Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects.
Guillermet-Guibert J; Lahlou H; Pyronnet S; Bousquet C; Susini C
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):535-51. PubMed ID: 16183526
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction of somatostatin receptors negatively controlling cell proliferation.
Ferjoux G; Bousquet C; Cordelier P; Benali N; Lopez F; Rochaix P; Buscail L; Susini C
J Physiol Paris; 2000; 94(3-4):205-10. PubMed ID: 11087998
[TBL] [Abstract][Full Text] [Related]
5. Drug design at peptide receptors: somatostatin receptor ligands.
Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptors and regulation of cell proliferation.
Bousquet C; Guillermet J; Vernejoul F; Lahlou H; Buscail L; Susini C
Dig Liver Dis; 2004 Feb; 36 Suppl 1():S2-7. PubMed ID: 15077905
[TBL] [Abstract][Full Text] [Related]
7. Cellular biology of somatostatin receptors.
Csaba Z; Dournaud P
Neuropeptides; 2001 Feb; 35(1):1-23. PubMed ID: 11346306
[TBL] [Abstract][Full Text] [Related]
8. Internalization of somatostatin receptors in brain and periphery.
Csaba Z; Dournaud P
Prog Mol Biol Transl Sci; 2023; 196():43-57. PubMed ID: 36813365
[TBL] [Abstract][Full Text] [Related]
9. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
[TBL] [Abstract][Full Text] [Related]
10. [New medical treatments in pituitary adenomas].
Drutel A; Caron P; Archambeaud F
Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S16-28. PubMed ID: 18954854
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic and diagnostic implications of the somatostatin system in gastroenteropancreatic neuroendocrine tumour disease.
Höcker M; Wiedenmann B
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S139-42. PubMed ID: 10604118
[TBL] [Abstract][Full Text] [Related]
12. New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting.
Ginj M; Zhang H; Eisenwiener KP; Wild D; Schulz S; Rink H; Cescato R; Reubi JC; Maecke HR
Clin Cancer Res; 2008 Apr; 14(7):2019-27. PubMed ID: 18381940
[TBL] [Abstract][Full Text] [Related]
13. Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors.
Feelders RA; de Herder WW; Neggers SJ; van der Lely AJ; Hofland LJ
Drugs Today (Barc); 2013 Feb; 49(2):89-103. PubMed ID: 23462624
[TBL] [Abstract][Full Text] [Related]
14. Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion.
Luque RM; Durán-Prado M; García-Navarro S; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
Endocrinology; 2006 Jun; 147(6):2902-8. PubMed ID: 16543371
[TBL] [Abstract][Full Text] [Related]
15. Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects.
Park S; Kamegai J; Kineman RD
Neuroendocrinology; 2003 Sep; 78(3):163-75. PubMed ID: 14512709
[TBL] [Abstract][Full Text] [Related]
16. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation.
Spary EJ; Maqbool A; Batten TF
J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081
[TBL] [Abstract][Full Text] [Related]
17. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation.
Ben-Shlomo A; Pichurin O; Barshop NJ; Wawrowsky KA; Taylor J; Culler MD; Chesnokova V; Liu NA; Melmed S
Mol Endocrinol; 2007 Oct; 21(10):2565-78. PubMed ID: 17609435
[TBL] [Abstract][Full Text] [Related]
18. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms.
Gatto F; Barbieri F; Arvigo M; Thellung S; Amarù J; Albertelli M; Ferone D; Florio T
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412614
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin and its receptor family.
Patel YC
Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
[TBL] [Abstract][Full Text] [Related]
20. Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning.
Durán-Prado M; Malagón MM; Gracia-Navarro F; Castaño JP
Mol Cell Endocrinol; 2008 May; 286(1-2):63-8. PubMed ID: 18242821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
